Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology

Journal of Sexual Medicine

Volumn 10, Issue 10, 2013, Pages 2598-2603

  Melcangi, Roberto Cosimo ^a   Caruso, Donatella ^a   Abbiati, Federico ^a   Giatti, Silvia ^a   Calabrese, Donato ^a   Piazza, Fabrizio ^b   Cavaletti, Guido ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

5 Reductase; Depression; Liquid Chromatography Tandem Mass Spectrometry; Progesterone; Testosterone

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; 5ALPHA ANDROSTANE DERIVATIVE; ANDROSTANOLONE; ESTRADIOL; FINASTERIDE; SEPRANOLONE; STEROID; TESTOSTERONE; TETRAHYDROPROGESTERONE;

ADULT; ALOPECIA; ANDROGENIC ALOPECIA; ANXIETY DISORDER; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG WITHDRAWAL; FATIGUE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MUSCLE CRAMP; MUSCLE RIGIDITY; OUTCOME ASSESSMENT; PLASMA; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; TANDEM MASS SPECTROMETRY; TREMOR;

5Α-REDUCTASE; DEPRESSION; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; PROGESTERONE; TESTOSTERONE;

5-ALPHA REDUCTASE INHIBITORS; ADULT; ALOPECIA; ANXIETY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DEPRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FINASTERIDE; HUMANS; MALE; SEXUAL BEHAVIOR; STEROIDS; TANDEM MASS SPECTROMETRY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885926631     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12269     Document Type: Article

References (23)

1. Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE, Wiren KM. A new look at the 5α-reductase inhibitor finasteride. CNS Drug Rev 2006;12:53-76.
2. Traish AM. 5α-reductases in human physiology: An unfolding story. Endocr Pract 2012;18:965-975.
3. Melcangi RC, Garcia-Segura LM, Mensah-Nyagan AG. Neuroactive steroids: State of the art and new perspectives. Cell Mol Life Sci 2008;65:777-797.
4. Handa RJ, Pak TR, Kudwa AE, Lund TD, Hinds L. An alternate pathway for androgen regulation of brain function: Activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5α-androstane-3β, 17β-diol. Horm Behav 2008;53:741-752.
5. Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 2006;55:1014-1023.
6. McClellan KJ, Markham A. Finasteride: A review of its use in male pattern hair loss. Drugs 1999;57:111-126.
7. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998;39:578-589.
8. Irwig MS. Persistent sexual side effects of finasteride: Could they be permanent? J Sex Med 2012;9:2927-2932.
9. Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med 2011;8:1747-1753.
10. Altomare G, Capella GL. Depression circumstantially related to the administration of finasteride for androgenetic alopecia. J Dermatol 2002;29:665-669.
11. Rahimi-Ardabili B, Pourandarjani R, Habibollahi P, Mualeki A. Finasteride induced depression: A prospective study. BMC Clin Pharmacol 2006;6:7.
12. Irwig MS. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. J Clin Psychiatry 2012;73:1220-1223.
13. Schumacher M, Hussain R, Gago N, Oudinet JP, Mattern C, Ghoumari AM. Progesterone synthesis in the nervous system: Implications for myelination and myelin repair. Front Neurosci 2012;6:10. doi: 10.3389/fnins.2012.00010
14. Panzica GC, Balthazart J, Frye CA, Garcia-Segura LM, Herbison AE, Mensah-Nyagan AG, McCarthy MM, Melcangi RC. Milestones on Steroids and the Nervous System: 10 years of basic and translational research. J Neuroendocrinol 2012;24:1-15.
15. Bitran D, Hilvers RJ, Kellogg CK. Anxiolytic effects of 3 α-hydroxy-5 α[β]-pregnan-20-one: Endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 1991;561:157-161.
16. Wang M, He Y, Eisenman LN, Fields C, Zeng CM, Mathews J, Benz A, Fu T, Zorumski E, Steinbach JH, Covey DF, Zorumski CF, Mennerick S. 3β-hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J Neurosci 2002;22:3366-3375.
17. Zorumski CF, Paul SM, Izumi Y, Covey DF, Mennerick S. Neurosteroids, stress and depression: Potential therapeutic opportunities. Neurosci Biobehav Rev 2013;37:109-122.
18. Caruso D, Pesaresi M, Maschi O, Giatti S, Garcia-Segura LM, Melcangi RC. Effects of short- and long-term gonadectomy on neuroactive steroid levels in the central and peripheral nervous system of male and female rats. J Neuroendocrinol 2010;22:1137-1147.
19. Caruso D, Barron AM, Brown MA, Abbiati F, Carrero P, Pike CJ, Garcia-Segura LM, Melcangi RC. Age-related changes in neuroactive steroid levels in 3×Tg-AD mice. Neurobiol Aging 2013;34:1080-1089.
20. Romeo E, Strohle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998;155:910-913.
21. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 1998;95:3239-3244.
22. Uzunova V, Sampson L, Uzunov DP. Relevance of endogenous 3α-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl) 2006;186:351-361.
23. Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5α-reductase inhibitors therapy: Persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med 2011;8:872-884.